# Flavanol Augmentation for Antidepressant Non-Responsive Late Life Depression

> **NCT02943096** · NA · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 6 (actual)

## Conditions studied

- Depression
- Major Depressive Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** CocoaVia
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02943096
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11
- **Primary completion:** 2018-02-06
- **Final completion:** 2018-02-06
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Study stopped due to funding limitations
- **Last updated:** 2019-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02943096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02943096, "Flavanol Augmentation for Antidepressant Non-Responsive Late Life Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02943096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*